EP3999499
PRODRUGS IN THE MODULATION OF INTERLEUKIN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.7.2020EP published:
4.9.2024EP application number:
20753523.8
EPO information:
European Patent Register
Max expiry date:
13.7.2040
Title in English:
PRODRUGS IN THE MODULATION OF INTERLEUKINLanguage of the patent:
English
Timeline
Today
14.7.2020EP application
4.9.2024EP Publication
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Inventor
Name:
MOSLIN, Ryan M.Address:
Princeton, New Jersey 08543, US
Name:
WEINSTEIN, David S.Address:
San Diego, California 92109, US
Name:
RAMAR, ThangeswaranAddress:
Bangalore 560099, IN
Name:
ANDAPPAN MURUGAIAH SUBBAIAH, MurugaiahAddress:
Bangalore 560099, IN
Priority
Number:
201962874531 PDate:
16.7.2019Country:
US
Classification
Categories:
C07D 401/12, C07D 403/12, A61P 29/00, A61P 37/00, A61K 31/4439, A61K 31/501